MDPH Releases 2017-2018 ACIP Influenza Recommendations
Wednesday, September 6, 2017
This year the Advisory Committee on Immunization Practices (ACIP) is publishing its recommendations regarding influenza vaccine in 3 separate documents. Below you will find the respective links:
2017-2018 ACIP influenza recommendations: CDC. Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP) - United States, 2017-18 Season. MMWR 2017; 66(RR-2):1-20. https://www.cdc.gov/mmwr/volumes/66/rr/pdfs/rr6602.pdf
o See pages 5 and 6 for the primary changes and updates, which are not extensive this year. Please note that live attenuated influenza vaccine (LAIV) should not be used during the 2017-2018 influenza season.
A summary of this year’s recommendations: CDC. Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization (ACIP) – United States, 2017-2018, Summary of Recommendations. Available at: https://www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/downloads/ACIP-recs-2017-18-summary.pdf
o This 4 page ‘Job Aid’ is a new document that contains all the critical recommendations, tables and flow charts.
And a background document for this year’s recommendations: Background Document for “Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices—United States, 2017-18 Influenza Season.” Available at https://www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/downloads/ACIP-recs-2017-18-bkgd.pdf
o This is also a new document that contains all of the background information, data and studies which informed the ACIP deliberations when making their recommendations about the use of influenza vaccine.
We have received a number of questions from providers concerning the correct dose volume of FluLaval Quadrivalent (IIV4), which is approved for use in children aged 6 months through 35 months as a 0.5mL intramuscular dose. This is the correct dose volume for this age group for this product. See the table below for more information.
Take Care to Use Correct Volume for Dose in Children
For anydose needed, children aged 6 through 35 months may receive either:
• 0.5mL FluLaval Quadrivalent (IIV4) intramuscularly, or
• 0.25mL Fluzone Quadrivalent (IIV4) intramuscularly.
• Note that dose volumediffersfor these two brands.
Care should be taken to administer the correct dose.
Children aged 3 through 17 years may receive 0.5 mL intramuscularly of an age-appropriate IIV formulation.
Please note: Children 6 months through 8 years who are receiving influenza vaccine for the 1sttime or who have had a total of only 1 dose of influenza vaccine in any previous seasons will need 2 doses separated by>4 weeks. For those children who need 2 doses this season, the 2 doses do not need to be the same product.
We will circulate our updated guidance for healthcare providers, guidance for long-term care, and model standing orders soon.
The influenza VIS is no longer updated each year, unless needed. The current flu VIS posted on the CDC website is the one you can use for this upcoming flu season. If you need VISs in other languages, please visit the http://www.immunize.org/vis/vis_flu_inactive.asp.
For questions about state supplied flu vaccine availability and ordering, please contact the Vaccine Management Unit at 617-983-6828.
For questions about flu vaccine recommendations, please call the Immunization Program at 617-983-6800 and ask to speak to an immunization epidemiologist.
Thanks for all your efforts to protect children and adults against influenza this season.
Susan M. Lett, MD, MPH
Medical Director, Immunization Program
Division of Epidemiology and Immunization
Massachusetts Department of Public Health
MDPH Website: www.mass.gov/dph